透皮医疗贴剂市场基于(主要地区、市场参与者、规模和份额)- 预测至 2028 年

  • Report Code : TIPRE00024652
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 194
Buy Now

Transdermal Medical Patch Market Size Report | 2023-2028

Buy Now

 

透皮医疗贴剂市场规模预计将从 2022 年的 82.4721 亿美元增至 2028 年的 107.9974 亿美元。预计 2023 年至 2028 年的复合年增长率为 4.0%。

 

分析师观点

慢性病患病率的上升和烟草消费量的增加推动了透皮医疗贴剂市场的增长。患有慢性病的患者数量不断增加以及研发活动的增加是推动透皮医疗贴剂市场的关键因素。此外,研发活动的增加预计将促进透皮医疗贴剂市场的增长。此外,透皮医疗贴剂市场的主要参与者正专注于战略举措,通过推出新产品来扩大其地理覆盖范围并增强满足庞大客户群的能力。例如,2021 年 3 月,久光制药株式会社宣布批准在日本生产和销售用于“癌症疼痛”的 ZICTHORU Tapes 75 毫克透皮止痛 NSAID 贴剂。该产品是一种使用久光的 TDDS(透皮给药系统)技术开发的全身透皮制剂。该产品的有效性和安全性已在癌症疼痛患者的临床试验中得到证实。

 

透皮医疗贴剂市场 - 市场概览

透皮医疗贴剂,也称为药用贴剂或皮肤贴剂,是一种医疗设备,旨在通过皮肤将药物或其他治疗物质输送到血液中。这些贴剂通常是薄的粘性贴剂,可直接贴在皮肤上,使药物在指定的时间内逐渐被吸收。透皮贴剂提供了一种方便的给药方法。它们可以贴在皮肤上并佩戴一段时间,通常为几小时到几天,具体取决于药物和所需的治疗效果。

 

定制研究以满足您的需求

我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

透皮医疗贴剂市场:

透皮医疗贴剂市场

  • 复合年增长率(2022 - 2028)
    4.0%
  • 2022 年市场规模
    82.5 亿美元
  • 2028 年市场规模
    108 亿美元

市场动态

增长动力
  • 慢性病患病率不断上升
  • 烟草消费量增长
未来的趋势
  • 智能贴片和三维 (3D) 打印贴片的进展
机会
  • 增加战略举措

关键人物;主力;重要一员

  •  
  • 久光制药株式会社
  • 美德林工业公司
  • 强生公司
  • 诺华公司
  • 梯瓦制药工业有限公司
  • 联合银行
  • 维他命公司
  • 远藤制药公司
  • 勃林格殷格翰国际有限公司

区域概况

  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

类型
  • 单层药物粘合剂
  • 多层药物粘合剂
  • 水库
  • 蒸气贴片
  • 矩阵
应用
  • 神经系统疾病
  • 疼痛管理
  • 戒除尼古丁
  • 心血管疾病
  • 激素治疗
  • 其他的
分销渠道
  • 医院药房
  • 零售药店
  • 网上药店
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

市场驱动因素

 

慢性病患病率上升推动全球透皮医疗贴剂市场

根据美国疾病控制与预防中心 (CDC) 的数据,心脏病、癌症和糖尿病等慢性病占美国每年医疗支出的很大一部分(41 亿美元)。透皮医用贴剂用于给患有心脏病、中风、糖尿病、癌症、肥胖症和关节炎等慢性病的人给药。根据世界卫生组织 (WHO) 的数据,2019 年约有 1790 万人死于心血管疾病,占全球记录的所有死亡人数的 32%。85% 的心血管疾病相关死亡是由于心脏病发作。根据同一来源,2019 年超过四分之三的心血管疾病死亡发生在中低收入国家,包括 1700 万人因非传染性疾病过早死亡(70 岁以下);心血管疾病是 38% 与非传染性疾病相关的死亡原因。

心脏贴片为细胞植入改进提供了极好的平台。例如,最近开发的血管化心脏贴片显示出治疗缺血性心脏损伤的良好潜力。硝酸甘油透皮贴片用于预防冠状动脉疾病患者的心绞痛(胸痛)。它的作用是放松血管,减少心脏压力,从而降低对氧气的需求。然而,这些贴片不能用于治疗已经开始的心绞痛发作。

2019 年,阿尔茨海默病被正式列为美国第六大死亡原因,2020 年和 2021 年则为第七大死亡原因。根据美国国立卫生研究院 2023 年的统计数据,约有 670 万美国人(即每 9 人中就有 1 人,即 10.8%)患有阿尔茨海默病,年龄在 65 岁及以上。阿尔茨海默病患者的比例随着年龄的增长而增加。65-74 岁人群中 5% 患有阿尔茨海默病,75-84 岁人群中 13.1% 患有阿尔茨海默病,85 岁及以上人群中 33.3% 患有阿尔茨海默病。根据2021年发表的《全球早发性痴呆患病率》报告,美国早发性痴呆的患病率估计为每10万名30-64岁人群中110人,即总共约20万美国人。因此,年龄在65岁以下的人也可能患上阿尔茨海默氏痴呆症。

利伐斯的明贴剂用于治疗轻度、中度或重度阿尔茨海默病引起的痴呆症(记忆丧失)或帕金森病引起的轻度至中度痴呆症。利伐斯的明和多奈哌齐是胆碱酯酶抑制剂,具有剂量反应关系,药物剂量越大,疗效越好。利伐斯的明是一种亲脂性和亲水性的小分子,从化学角度来看非常适合透皮给药。利伐斯的明贴剂所采用的技术使其外观小巧纤薄。因此,利伐斯的明贴剂可以快速轻松地获得高剂量疗效。

因此,慢性病的日益流行催化了对医疗贴剂的需求,从而带来了透皮医疗贴剂市场的增长。

 

  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

透皮医疗贴剂市场 - 细分分析

 

根据类型,透皮医疗贴剂市场细分为单层药物粘合剂、多层药物粘合剂、储液器、蒸汽贴剂和基质。基质部分在 2022 年占据了最大的市场份额,预计同一部分在预测期内的复合年增长率最高,为 5.3%。该部分的市场地位归功于患者的依从性和便利性。基质贴剂的设计具有进一步提高患者依从性的功能,例如延长佩戴时间、简化应用或智能监控功能以跟踪药物依从性。基质贴剂结合了传感器或监控功能,可提供有关患者健康状况的实时反馈。   

 

药品
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

透皮医疗贴剂市场 - 区域分析

 

亚太地区是透皮医疗贴剂市场的主导地区。2022 年亚太地区透皮医疗贴剂市场价值为 20.2432 亿美元,预计到 2028 年将达到 27.4432 亿美元;预计在预测期内,复合年增长率为 5.2%。亚太地区透皮医疗贴剂市场分为中国、日本、印度和亚太其他地区。区域增长归因于对癌症和基因突变的研究不断增加、疾病建模不断增加以及提供透皮医疗贴剂的市场参与者的发展。医疗设施的发展、老龄化人口的增长以分享与干细胞技术相关的关键事实以及与外国实体的伙伴关系不断增加等因素可能会在预测期内进一步推动透皮医疗贴剂市场的增长。

 

透皮医疗贴剂市场 - 关键参与者分析

透皮医疗贴剂市场分析包括 Hisamitsu Pharmaceutical Co Inc、Medline Industries LP、Johnson & Johnson、Novartis AG、Teva Pharmaceutical Industries Ltd、UCB SA、Viatris Inc、Endo Pharmaceuticals Inc、Boehringer Ingelheim International GmbH 和 Corium, LLC 等参与者。在透皮医疗贴剂市场参与者中,Hisamitsu Pharmaceutical Co Inc 和 Novartis AG 凭借其提供的多样化产品组合位居前两位。

 

透皮医疗贴剂市场 - 最新发展

透皮医疗贴剂市场中的公司普遍采用并购等无机和有机策略。以下列出了一些近期的关键市场发展:

  • 2019 年,日东电工株式会社宣布推出与东亚荣阳株式会社共同开发的含 β1 阻滞剂的透皮贴剂 Bisono Tape 2mg,由东亚荣阳和安斯泰来制药公司推出。
  • 2022 年 6 月,久光制药株式会社的 ZICTHORU Tapes(透皮、止痛 NSAID 贴剂)在日本获批用于“腰痛、肱肩周炎、颈肩臂综合征和腱鞘炎”的附加适应症。该产品于 2021 年 3 月获批用于“各种癌症的镇痛”的生产和营销。此次批准基于 III 期临床研究的数据,该研究评估了该产品对腰痛、肱肩周炎、颈肩臂综合征和腱鞘炎患者的疗效和安全性。随着附加适应症的获批,久光制药预计该产品将成为治疗腰痛、肱肩周炎、颈肩臂综合征和腱鞘炎的新选择。
  • 2021 年 1 月,久光制药株式会社已在美国启动用于治疗骨关节炎膝关节疼痛的透皮止痛消炎贴剂的 III 期临床研究。该临床研究将由其美国子公司 Noven Pharmaceuticals, Inc. 进行。研究产品是一种使用久光的 TDDS(透皮给药系统)技术开发的透皮制剂。久光制药希望研究产品将成为治疗膝关节骨关节炎的一种新选择,通过实现更高的药物输送到患处(这是透皮制剂的属性之一)来展示其有效性和安全性。
  • 2022 年 9 月,Corium, Inc 推出了 ADLARITY(多奈哌齐透皮系统),目前可在美国处方用于治疗轻度、中度或重度阿尔茨海默病痴呆症患者。

透皮医疗贴剂市场报告范围

报告属性细节
2022 年市场规模82.5亿美元
2028 年市场规模108亿美元
全球复合年增长率(2022 - 2028)4.0%
历史数据2020-2021
预测期2023-2028
涵盖的领域按类型
  • 单层药物粘合剂
  • 多层药物粘合剂
  • 水库
  • 蒸气贴片
  • 矩阵
按应用
  • 神经系统疾病
  • 疼痛管理
  • 戒除尼古丁
  • 心血管疾病
  • 激素治疗
  • 其他的
按分销渠道
  • 医院药房
  • 零售药店
  • 网上药店
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  •  
  • 久光制药株式会社
  • 美德林工业公司
  • 强生公司
  • 诺华公司
  • 梯瓦制药工业有限公司
  • 联合银行
  • 维他命公司
  • 远藤制药公司
  • 勃林格殷格翰国际有限公司
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which segment by type led the transdermal medical patch market?

The matrix segment held the largest share of the market in 2022. Also, the same segment is estimated to register the highest CAGR in the market during the forecast period.

What is the market CAGR value of the transdermal medical patch market during the forecast period?

The CAGR value of the transdermal medical patch market during the forecasted period of 2023-2028 is 4.0%.

What are the driving factors for the global transdermal medical patch market across the world?

The factors that are driving the growth of the transdermal medical patch market are the increasing aging population, increasing prevalence of chronic diseases and growing consumption of tobacco and increasing partnerships with foreign entities. These are some of the major factors contributing to the growth of the transdermal medical patch industry.

Which region is projected to be the fastest-growing region in the global transdermal medical patch market?

The Asia Pacific is expected to be the fastest-growing region in the transdermal medical patch market over the forecast period due to the increasing prevalence of chronic diseases and the growing research on cancer and gene mutations, increasing disease modeling, and developments by market players offering transdermal medical patch.

What are the growth estimates for the transdermal medical patch market till 2028?

The transdermal medical patch market is expected to be valued at US$ 10,799.74 million in 2028.

Who are the major players in the transdermal medical patch market across the globe?

The transdermal medical patch market majorly consists of the players, such as Hisamitsu Pharmaceutical Co Inc, Medline Industries LP, Johnson & Johnson, Novartis AG, Teva Pharmaceutical Industries Ltd, UCB SA, Viatris Inc, Endo Pharmaceuticals Inc, Boehringer Ingelheim International GmbH, and Corium, LLC.

What are transdermal medical patch?

The transdermal medical patch is a medicated patch that can deliver drugs through skin portals directly to the bloodstream at a predetermined rate. This is the most comfortable dosage form – it is non-invasive, avoids the gastrointestinal tract and bypasses first-pass metabolism, can have multiday therapy, and can be terminated at any time.

What is the estimated transdermal medical patch market size in 2022?

The transdermal medical patch market is estimated to be valued at US$ 8,247.21 million in 2022.

The List of Companies - Transdermal Medical Patch Market

  1. Hisamitsu Pharmaceutical Co Inc
  2. Medline Industries LP
  3. Johnson & Johnson
  4. Novartis AG
  5. Teva Pharmaceutical Industries Ltd
  6. UCB SA
  7. Viatris Inc
  8. Endo Pharmaceuticals Inc
  9. Boehringer Ingelheim International GmbH
  10. Corium, LLC

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports